Shenzhen Neptunus Bioengineering Co., Ltd.

Equities

000078

CNE000000X95

Pharmaceuticals

End-of-day quote Shenzhen S.E. 03:30:00 10/05/2024 am IST 5-day change 1st Jan Change
2.48 CNY -1.98% Intraday chart for Shenzhen Neptunus Bioengineering Co., Ltd. +6.44% -21.02%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Neptunus Bioengineering to Build Smart Logistics Park for 298 Million Yuan MT
Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
UK Output Weakness Adds to BOE's Challenge DJ
Shenzhen Neptunus Bioengineering to Set Up 150 Million Yuan Medical Equipment Unit MT
FTSE 100 Closes Down 1.4% on US Credit Rating -2- DJ
Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Sector Update: Tech Stocks Edging Higher by Wednesday Close MT
Sector Update: Tech MT
FinVolution's Shares Fall Wednesday as Citigroup Downgrade Follows Lower Q4 Non-GAAP Earnings, Net Revenue MT
FinVolution Group's Q4 Non-GAAP Earnings Decline, Revenue Rises; CEO Steps Down; Annual Dividend Raised MT
Sterling May Fall Vs Euro as ECB More Aggressive -2- DJ
Shenzhen Neptunus Bioengineering Warns of Loss in 2022 MT
Sterling Could Turn Lower Vs Dollar After Recent Gains DJ
Shenzhen Neptunus Bioengineering Co., Ltd. Announces Executive Appointments CI
Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
FTSE 100 Closed Up Amid Falling Gas Prices, US Inflation Hopes DJ
FTSE 100 Rises as Traders Eye Key US Inflation Data DJ
Bets Against Pound Rise Amid Fears Over UK Growth, Fiscal Policy DJ
Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Hongta Securities Chairman, Two Others Resign as H1 Profit Halves MT
Sterling to Be Little Affected by UK Leadership Debate DJ
Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chart Shenzhen Neptunus Bioengineering Co., Ltd.
More charts
Shenzhen Neptunus Bioengineering Co.,Ltd is a China-based company principally engaged in pharmaceutical and food manufacturing and pharmaceutical commercial distribution businesses. The Company’s main products include anti-tumor products, cardiovascular drugs, marine drugs, respiratory drugs, anti-infective products and other pharmaceuticals, as well as healthcare products, health food and medical instrument. The Company distributes its products mainly in domestic market, with East China as its main market.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000078 Stock
  4. News Shenzhen Neptunus Bioengineering Co., Ltd.
  5. Shenzhen Neptunus Bioengineering to Set Up 150 Million Yuan Medical Equipment Unit
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW